Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (181-190 of 358) with videos related to

Pageof 36
Sort By:
Translational Neurodegeneration|March 14, 2023
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathiesMatthias Schmitz, Niccolò Candelise, Sezgi Canaslan, et al.
Journal of Neurology|December 12, 2024
Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditionsFabian Maass, Sezgi Canaslan, Christoph van Riesen, et al.
Frontiers in Psychiatry|October 16, 2020
Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune EncephalitisNiels Hansen, Sina Hirschel, Winfried Stöcker, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 22, 2022
The prion protein and its ligands: Insights into structure-function relationshipsMohsin Shafiq, Stefano Da Vela, Ladan Amin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2021
Validation of Plasma Neurofilament Light Chain as a Marker for α-SynucleinopathiesMatthias Schmitz, Sezgi Canaslan, Anna Villar-Piqué, et al.
European Journal of Epidemiology|June 17, 2015
Clinical findings and diagnosis in genetic prion diseases in GermanyAnna Krasnianski, Uta Heinemann, Claudia Ponto, et al.
Journal of Psychiatric Research|May 18, 2010
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophreniaDaniel Martins-de-Souza, Giuseppina Maccarrone, Thomas Wobrock, et al.
Alzheimer'S Research & Therapy|April 22, 2021
Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob diseaseInga Zerr, Anna Villar-Piqué, Peter Hermann, et al.
Frontiers in Aging Neuroscience|October 11, 2021
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-SynucleinopathiesSezgi Canaslan, Matthias Schmitz, Anna Villar-Piqué, et al.
The New England Journal of Medicine|May 10, 2023
Detection of Prion Protein Seeding Activity in Tear FluidsMatthias Schmitz, Susana Silva Correia, Peter Hermann, et al.
Pageof 36

Showing results (181-190 of 358) with videos related to

Sort By:
Pageof 36
Translational Neurodegeneration|March 14, 2023
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathiesMatthias Schmitz, Niccolò Candelise, Sezgi Canaslan, et al.
Journal of Neurology|December 12, 2024
Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditionsFabian Maass, Sezgi Canaslan, Christoph van Riesen, et al.
Frontiers in Psychiatry|October 16, 2020
Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune EncephalitisNiels Hansen, Sina Hirschel, Winfried Stöcker, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 22, 2022
The prion protein and its ligands: Insights into structure-function relationshipsMohsin Shafiq, Stefano Da Vela, Ladan Amin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2021
Validation of Plasma Neurofilament Light Chain as a Marker for α-SynucleinopathiesMatthias Schmitz, Sezgi Canaslan, Anna Villar-Piqué, et al.
European Journal of Epidemiology|June 17, 2015
Clinical findings and diagnosis in genetic prion diseases in GermanyAnna Krasnianski, Uta Heinemann, Claudia Ponto, et al.
Journal of Psychiatric Research|May 18, 2010
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophreniaDaniel Martins-de-Souza, Giuseppina Maccarrone, Thomas Wobrock, et al.
Alzheimer'S Research & Therapy|April 22, 2021
Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob diseaseInga Zerr, Anna Villar-Piqué, Peter Hermann, et al.
Frontiers in Aging Neuroscience|October 11, 2021
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-SynucleinopathiesSezgi Canaslan, Matthias Schmitz, Anna Villar-Piqué, et al.
The New England Journal of Medicine|May 10, 2023
Detection of Prion Protein Seeding Activity in Tear FluidsMatthias Schmitz, Susana Silva Correia, Peter Hermann, et al.
Pageof 36